Cyxone Investor Relations Material
Latest events
Q2 2024
29 Aug, 2024
Q1 2024
14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cyxone
Access all reports
Cyxone is a Swedish biotechnology company focused on developing innovative treatments for autoimmune and immune-related diseases. The company's research and development efforts center on creating therapies that modulate the immune system to treat conditions such as rheumatoid arthritis and multiple sclerosis. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CYXO
Country
🇸🇪 Sweden